Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unilab is the largest pharmaceutical and healthcare company in the Philippines, maintaining a dominant market share and a significant presence across Southeast Asia. Founded in 1945, the company manufactures and markets an extensive portfolio of over 300 brands, including prescription medications, over-the-counter drugs, vitamins, and personal care products. Unilab operates a robust network of world-class manufacturing facilities, such as Amherst Laboratories, which comply with international current Good Manufacturing Practice (cGMP) standards. The company is recognized for its strong research and development capabilities, focusing on both high-quality generic formulations and innovative healthcare solutions. Through its various subsidiaries and divisions like Bio-Onco and RiteMED, Unilab provides affordable and accessible healthcare to millions of consumers in the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unilab Life Science.